Form 4 Filing for Ware Olivia C

This Form 4 filing details a stock option grant to Ware Olivia C, a director at Contineum Therapeutics, Inc. The option, for 19,000 shares of Class A Common Stock, was granted on June 26, 2026, under the company's 2024 Equity Incentive Plan. The option has an exercise price of $14.19 and will vest in full on the earlier of June 26, 2027, or the next annual stockholder meeting, contingent upon continuous service. The option expires on June 25, 2036. This transaction is classified as an acquisition of securities.